SCHEMBL16626636

SCHEMBL16626636

CNCc1cn(S(=O)(=O)c2cccnc2)c2cc(Cc3ccc(C)cc3Cl)ccc12

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.42
PDE4B Q07343 2/20 0.42
PDE4C Q08493 2/20 0.42
PDE4D Q08499 2/20 0.42
ALK Q9UM73 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
IDE P14735 1/20 0.37
HTR6 P50406 4/20 0.36
CYP19A1 P11511 1/20 0.36
NAMPT P43490 2/20 0.35
HSP90AA1 P07900 1/20 0.34
TSHR P16473 1/20 0.34
HPGD P15428 1/20 0.33
LMNA P02545 1/20 0.33
CLK1 P49759 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
TNFSF11 O14788 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL16618813 0.99 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DALK
SCHEMBL17971580 0.91 ALK (0.41) PDE4APDE4BPDE4CPDE4DALK
SCHEMBL17971579 0.90 SLC6A2 (0.38) PDE4APDE4BPDE4CPDE4DSLC6A2
Hydrochloric Acid SCHEMBL16618994 0.90 SLC6A2 (0.37) PDE4APDE4BPDE4CPDE4DSLC6A2
SCHEMBL17971577 0.90 ALK (0.38) PDE4APDE4BPDE4CPDE4DALK
SCHEMBL17971576 0.89 PDE4A (0.42) PDE4APDE4BPDE4CPDE4DALK
SCHEMBL16626751 0.89 CYP3A4 (0.37) PDE4APDE4BPDE4CPDE4DSLC6A2
Hydrochloric Acid SCHEMBL16619344 0.89 ALK (0.38) PDE4APDE4BPDE4CPDE4DALK
Hydrochloric Acid SCHEMBL16618893 0.88 CYP3A4 (0.37) PDE4APDE4BPDE4CPDE4DSLC6A2
Hydrochloric Acid SCHEMBL16618987 0.88 PDE4A (0.41) PDE4APDE4BPDE4CPDE4DALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP claimed
EP-3052484-B1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAE WOONG PHARMA (KR) 2018-03-21 EP disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-9676714-B2 Sulfonylindole derivatives and method for preparing the same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2017-06-13 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2016-08-04 US disclosed
WO-2015050412-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160221946-A1 SULFONYLINDOLE DERIVATIVES AND METHOD FOR PREPARING THE SAME GIPR, PGC, SI PDE4A 2460/4885PDE4B 1996/4885PDE4C 3748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.